The global Enteral Stents Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Stent (Esophageal Stents, Gastroduodenal Stents, Colon Stents), By Product (Self-Expandable Metal Stents, Self-Expandable Plastic Stents), By End-User (Hospitals, Specialty Clinics, Ambulatory Centers, Research Centers).
The Enteral Stents Market encompasses medical devices used for endoscopic placement in the gastrointestinal (GI) tract to relieve obstructions, maintain luminal patency, and facilitate enteral nutrition delivery. These stents, made from materials like metal alloys or polymers, provide structural support to diseased or narrowed GI segments affected by strictures, tumors, or other conditions. With a focus on improving patient comfort, reducing complications, and enhancing nutritional support, the enteral stents market plays a vital role in gastroenterology and interventional endoscopy, offering minimally invasive solutions for GI tract management.
The global Enteral Stents Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Enteral Stents Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Enteral Stents Industry include- Abbott Laboratories, Aetna Inc, B. Braun Melsungen AG, Becton, Dickinson and Company, Biosensors International Group Ltd, Boston Scientific Corp, BVM Medical Ltd, Cardinal Health, Changzhou Health Microport Medical Device Co. Ltd, Cook, ELLA – CS s.r.o., ENDO-FLEX GmbH., GBUK Group Ltd, M.I.TECH., Medtronic Plc, Merit Medical Systems, Micro-Tech Co. Ltd, Stryker Corp, TAEWOONG, Terumo Europe NV.
In the realm of Enteral Stents, a notable trend is the expansion of indications and the development of improved stent designs to address various gastrointestinal conditions. Manufacturers are continuously expanding the range of indications for enteral stents beyond strictures, including palliative care for malignant obstructions, treatment of leaks and fistulas, and management of benign conditions such as strictures and perforations. Additionally, there is a focus on enhancing stent designs to improve patency, prevent migration, and reduce the risk of complications such as tissue ingrowth and stent-related symptoms. This trend is driven by the demand for minimally invasive treatment options that offer symptom relief, restore luminal patency, and improve quality of life for patients with gastrointestinal disorders.
The primary driver for the Enteral Stents market is the increasing incidence of gastrointestinal diseases and the growing adoption of endoscopic interventions for their management. Gastrointestinal conditions such as colorectal cancer, esophageal cancer, and benign strictures are common and often require interventions to relieve symptoms and improve patient outcomes. Endoscopic placement of enteral stents offers a minimally invasive alternative to surgery for palliation and treatment of luminal obstructions, providing patients with symptom relief and improved quality of life. Additionally, advancements in endoscopic techniques, imaging modalities, and stent technology have expanded the indications for enteral stent placement, driving market growth and adoption within the field of gastrointestinal endoscopy.
An opportunity exists in the development of biodegradable and drug-eluting stent technologies within the Enteral Stents market. Biodegradable stents offer the potential for temporary luminal support while promoting tissue healing and remodeling, ultimately leading to stent degradation and tissue integration. Drug-eluting stents, on the other hand, can deliver therapeutic agents such as anti-inflammatory drugs or chemotherapeutic agents directly to the target site, reducing the risk of restenosis and improving long-term outcomes. Companies can capitalize on this opportunity by investing in research and development to create biodegradable and drug-eluting stent platforms tailored to the specific needs of gastrointestinal interventions. Additionally, there is potential for the development of customizable stent delivery systems and deployment techniques to optimize procedural outcomes and patient safety. By embracing innovation in stent technology, companies can drive market growth and improve treatment options for patients with gastrointestinal disorders.
Among the listed categories, esophageal stents are experiencing the fastest growth. Esophageal stents are medical devices used to treat various conditions affecting the esophagus, such as strictures, obstructions, and perforations. They are designed to provide structural support and maintain patency in the esophageal lumen, thereby relieving dysphagia and facilitating the passage of food and fluids. Esophageal stents play a crucial role in the palliative treatment of esophageal cancer, as well as in the management of benign conditions such as strictures and leaks. The rapid growth in the adoption of esophageal stents can be attributed to several factors, including the increasing incidence of esophageal disorders worldwide, advancements in stent technology leading to improved efficacy and safety profiles, and the rising preference for minimally invasive treatment options. Hospitals, specialty clinics, ambulatory centers, and research centers are the primary end-users where esophageal stents are utilized, reflecting their widespread application across various healthcare settings. As the demand for minimally invasive interventions for esophageal conditions continues to rise, the market for esophageal stents is expected to expand further, driving innovation and advancements in stent design and delivery techniques.
By Stent
Esophageal Stents
Gastroduodenal Stents
Colon Stents
By Product
Self-Expandable Metal Stents
Self-Expandable Plastic Stents
By End-User
Hospitals
Specialty Clinics
Ambulatory Centers
Research Centers
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
Aetna Inc
B. Braun Melsungen AG
Becton, Dickinson and Company
Biosensors International Group Ltd
Boston Scientific Corp
BVM Medical Ltd
Cardinal Health
Changzhou Health Microport Medical Device Co. Ltd
Cook
ELLA – CS s.r.o.
ENDO-FLEX GmbH.
GBUK Group Ltd
M.I.TECH.
Medtronic Plc
Merit Medical Systems
Micro-Tech Co. Ltd
Stryker Corp
TAEWOONG
Terumo Europe NV
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Enteral Stents Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Enteral Stents Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Enteral Stents Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Enteral Stents Market Size Outlook, $ Million, 2021 to 2030
3.2 Enteral Stents Market Outlook by Type, $ Million, 2021 to 2030
3.3 Enteral Stents Market Outlook by Product, $ Million, 2021 to 2030
3.4 Enteral Stents Market Outlook by Application, $ Million, 2021 to 2030
3.5 Enteral Stents Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Enteral Stents Industry
4.2 Key Market Trends in Enteral Stents Industry
4.3 Potential Opportunities in Enteral Stents Industry
4.4 Key Challenges in Enteral Stents Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Enteral Stents Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Enteral Stents Market Outlook by Segments
7.1 Enteral Stents Market Outlook by Segments, $ Million, 2021- 2030
By Stent
Esophageal Stents
Gastroduodenal Stents
Colon Stents
By Product
Self-Expandable Metal Stents
Self-Expandable Plastic Stents
By End-User
Hospitals
Specialty Clinics
Ambulatory Centers
Research Centers
8 North America Enteral Stents Market Analysis and Outlook To 2030
8.1 Introduction to North America Enteral Stents Markets in 2024
8.2 North America Enteral Stents Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Enteral Stents Market size Outlook by Segments, 2021-2030
By Stent
Esophageal Stents
Gastroduodenal Stents
Colon Stents
By Product
Self-Expandable Metal Stents
Self-Expandable Plastic Stents
By End-User
Hospitals
Specialty Clinics
Ambulatory Centers
Research Centers
9 Europe Enteral Stents Market Analysis and Outlook To 2030
9.1 Introduction to Europe Enteral Stents Markets in 2024
9.2 Europe Enteral Stents Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Enteral Stents Market Size Outlook by Segments, 2021-2030
By Stent
Esophageal Stents
Gastroduodenal Stents
Colon Stents
By Product
Self-Expandable Metal Stents
Self-Expandable Plastic Stents
By End-User
Hospitals
Specialty Clinics
Ambulatory Centers
Research Centers
10 Asia Pacific Enteral Stents Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Enteral Stents Markets in 2024
10.2 Asia Pacific Enteral Stents Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Enteral Stents Market size Outlook by Segments, 2021-2030
By Stent
Esophageal Stents
Gastroduodenal Stents
Colon Stents
By Product
Self-Expandable Metal Stents
Self-Expandable Plastic Stents
By End-User
Hospitals
Specialty Clinics
Ambulatory Centers
Research Centers
11 South America Enteral Stents Market Analysis and Outlook To 2030
11.1 Introduction to South America Enteral Stents Markets in 2024
11.2 South America Enteral Stents Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Enteral Stents Market size Outlook by Segments, 2021-2030
By Stent
Esophageal Stents
Gastroduodenal Stents
Colon Stents
By Product
Self-Expandable Metal Stents
Self-Expandable Plastic Stents
By End-User
Hospitals
Specialty Clinics
Ambulatory Centers
Research Centers
12 Middle East and Africa Enteral Stents Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Enteral Stents Markets in 2024
12.2 Middle East and Africa Enteral Stents Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Enteral Stents Market size Outlook by Segments, 2021-2030
By Stent
Esophageal Stents
Gastroduodenal Stents
Colon Stents
By Product
Self-Expandable Metal Stents
Self-Expandable Plastic Stents
By End-User
Hospitals
Specialty Clinics
Ambulatory Centers
Research Centers
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Aetna Inc
B. Braun Melsungen AG
Becton, Dickinson and Company
Biosensors International Group Ltd
Boston Scientific Corp
BVM Medical Ltd
Cardinal Health
Changzhou Health Microport Medical Device Co. Ltd
Cook
ELLA – CS s.r.o.
ENDO-FLEX GmbH.
GBUK Group Ltd
M.I.TECH.
Medtronic Plc
Merit Medical Systems
Micro-Tech Co. Ltd
Stryker Corp
TAEWOONG
Terumo Europe NV
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Stent
Esophageal Stents
Gastroduodenal Stents
Colon Stents
By Product
Self-Expandable Metal Stents
Self-Expandable Plastic Stents
By End-User
Hospitals
Specialty Clinics
Ambulatory Centers
Research Centers
The global Enteral Stents Market is one of the lucrative growth markets, poised to register a 5.6% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, Aetna Inc, B. Braun Melsungen AG, Becton, Dickinson and Company, Biosensors International Group Ltd, Boston Scientific Corp, BVM Medical Ltd, Cardinal Health, Changzhou Health Microport Medical Device Co. Ltd, Cook, ELLA – CS s.r.o., ENDO-FLEX GmbH., GBUK Group Ltd, M.I.TECH., Medtronic Plc, Merit Medical Systems, Micro-Tech Co. Ltd, Stryker Corp, TAEWOONG, Terumo Europe NV
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume